Haploidentical Bone Marrow Transplantation in 2015 and Beyond-Reference-Cited by-同舟云学术

Haploidentical Bone Marrow Transplantation in 2015 and Beyond

Published:2015-10-14 Issue:12 Volume:17 Page:
ISSN:1523-3790
Container-title:Current Oncology Reports
language:en
Short-container-title:Curr Oncol Rep

Author:

Ruiz-Argüelles Guillermo J.,Ruiz-Delgado Guillermo J.,González-Llano Oscar,Gómez-Almaguer David

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11912-015-0482-9.pdf

Reference31 articles.

1. Fuchs EJ. Haploidentical transplantation for hematological malignancies: where do we stand? Hematology Am Soc Hematol Educ Program. 2012;2012:230–6. A comprehensive review by an expert.

2. González-Llano O, Rodríguez-Romo LN, Mancías-Guerra C, Tarín-Arzaga L, Jaime-Pérez JC, Herrera-Garza L, et al. Feasibility of an outpatient HLA haploidentical stem cell transplantation program in children using a reduced-intensity conditioning regimen and CD3–CD19 depletion. Hematology. 2014;19:10–7. Description of an haplo-SCT program, using ex vivo T cell depletion with CliniMacs and conducted on an outpatient basis employing reduced intensity conditioning; expensive procedure stemming from the costs of the ex vivo procedure.

3. Ruiz-Delgado GJ, Mancías-Guerra C, Macías-Gallardo J, González-Llano O, Hernández-Arizpe A, Rodríguez-Romo LN, Martínez-Cabriales SA, Gómez-Almaguer D, Ruiz-Argüelles GJ. Long term results of placental blood allografting using reduced-intensity conditioning: multicenter experience in a developing country. Hematology. 2011;16:155–159. The paper describes a low engraftment rate of cord blood hematopoietic cells apparently stemming from a suboptimal quality of the cords.

4. Munchel A, Kesserwan C, Symons HJ, Luznik L, Kasamon YL, Jones RJ, et al. Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post transplantation cyclophosphamide. Pediatr Rep. 2011;3(Suppl2):e15.

5. O´Donnell PV, Luznik L, Jones RJ, Vogelsang GB, Lefell MS, Phelps M, et al. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using postransplantation cyclophosphamide. Biol Blood Marrow Transpl. 2002;8:377–86. First paper describing in vivo T cell depletion by means of post-allograft cyclophosphamide.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Donor selection in allogeneic stem cell transplantation;Current Opinion in Hematology;2024-07-16

2. Haploidentical Stem Cell Transplantation for Hematological Disorders: Real-World Experience from India;South Asian Journal of Cancer;2023-09-27

3. Can doses of post-transplantation cyclophosphamide in haploidentical stem cell allografts be reduced?;Hematology;2023-08-02

4. Conducting hematopoietic stem cell transplantation in low and middle income countries;Hematology;2022-07-27

5. Bien plus Encore: Haplos Indeed Can be Completed on an Outpatient Basis;Transplantation and Cellular Therapy;2021-06